143 related articles for article (PubMed ID: 23431217)
1. Interpretation of subgroup effects in published trials.
Hancock MJ; Kjaer P; Korsholm L; Kent P
Phys Ther; 2013 Jun; 93(6):852-9. PubMed ID: 23431217
[TBL] [Abstract][Full Text] [Related]
2. Rudiments of subgroup analyses.
Moyé LA
Prog Cardiovasc Dis; 2012; 54(4):338-42. PubMed ID: 22226001
[TBL] [Abstract][Full Text] [Related]
3. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
Hemmings R
J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
[TBL] [Abstract][Full Text] [Related]
4. Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group).
Gelber RD; Goldhirsch A
J Natl Cancer Inst Monogr; 1992; (11):59-69. PubMed ID: 1385720
[TBL] [Abstract][Full Text] [Related]
5. Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?
Abrahamowicz M; Beauchamp ME; Fournier P; Dumont A
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1178-88. PubMed ID: 23939947
[TBL] [Abstract][Full Text] [Related]
6. Subgroups: time to go back to basic statistical principles?
Keene ON; Garrett AD
J Biopharm Stat; 2014; 24(1):58-71. PubMed ID: 24392978
[TBL] [Abstract][Full Text] [Related]
7. Understanding results.
Breau RH; Dahm P; Fergusson DA; Hatala R
J Urol; 2009 Mar; 181(3):985-92. PubMed ID: 19150555
[TBL] [Abstract][Full Text] [Related]
8. Interaction effects and subgroup analyses in clinical trials: more than meets the eye?
Sevdalis N; Jacklin R
J Eval Clin Pract; 2008 Oct; 14(5):919-22. PubMed ID: 18373582
[TBL] [Abstract][Full Text] [Related]
9. Intervention effects in the case of heterogeneity between three subgroups. Assessment within the framework of systematic reviews.
Skipka G; Bender R
Methods Inf Med; 2010; 49(6):613-7. PubMed ID: 20644897
[TBL] [Abstract][Full Text] [Related]
10. A flexible strategy for testing subgroups and overall population.
Alosh M; Huque MF
Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
[TBL] [Abstract][Full Text] [Related]
11. A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions.
Hancock M; Herbert RD; Maher CG
Phys Ther; 2009 Jul; 89(7):698-704. PubMed ID: 19465372
[TBL] [Abstract][Full Text] [Related]
12. Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.
Lipkovich I; Dmitrienko A; Denne J; Enas G
Stat Med; 2011 Sep; 30(21):2601-21. PubMed ID: 21786278
[TBL] [Abstract][Full Text] [Related]
13. The value of RCT evidence depends on the quality of statistical analysis.
Faulkner C; Fidler F; Cumming G
Behav Res Ther; 2008 Feb; 46(2):270-81. PubMed ID: 18191102
[TBL] [Abstract][Full Text] [Related]
14. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
[TBL] [Abstract][Full Text] [Related]
15. The role of the minimum clinically important difference and its impact on designing a trial.
Chuang-Stein C; Kirby S; Hirsch I; Atkinson G
Pharm Stat; 2011; 10(3):250-6. PubMed ID: 20936625
[TBL] [Abstract][Full Text] [Related]
16. Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples.
Schmidt AF; Rovers MM; Klungel OH; Hoes AW; Knol MJ; Nielen M; de Boer A; Groenwold RH
J Clin Epidemiol; 2013 Jun; 66(6):599-607. PubMed ID: 23510555
[TBL] [Abstract][Full Text] [Related]
17. Evidence based evaluation of immuno-coagulatory interventions in critical care.
Afshari A
Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
[TBL] [Abstract][Full Text] [Related]
18. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
[TBL] [Abstract][Full Text] [Related]
19. Using evidence in pain practice: Part II: Interpreting and applying systematic reviews and clinical practice guidelines.
Chou R
Pain Med; 2008; 9(5):531-41. PubMed ID: 18346061
[TBL] [Abstract][Full Text] [Related]
20. An overview of statistical planning to address subgroups in confirmatory clinical trials.
Koch GG; Schwartz TA
J Biopharm Stat; 2014; 24(1):72-93. PubMed ID: 24392979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
